A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus (VC01-103 Trial)
Recruiting in Palo Alto (17 mi)
+3 other locations
Overseen ByManasi Jaiman, MD
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 1 & 2
Waitlist Available
Sponsor: ViaCyte
No Placebo Group
Trial Summary
What is the purpose of this trial?This trial will test if implanting new cells can safely and effectively help people with Type 1 Diabetes control their blood sugar levels over time.
Eligibility Criteria
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Sentinel units (aka Cohort 1)Experimental Treatment1 Intervention
VC-01 Combination Product; Up to ten (10) VC-01 sentinels
Group II: Dose-finding units (aka Cohort 2)Experimental Treatment1 Intervention
VC-01 Combination Product; Up to twelve units implanted of which up to nine (9) are VC-01-DF (dose-finding) implants and the rest are VC-01 sentinels
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
Atlanta Diabetes AssociatesAtlanta, GA
Diablo Clinical ResearchWalnut Creek, CA
Texas Diabetes & EndocrinologyAustin, TX
AMCR InstituteEscondido, CA
Loading ...
Who is running the clinical trial?
ViaCyteLead Sponsor